Biotech Values

[Jonathan Robinson]

I do not think Boger meant on an ITT basis given the various reasons folks fall out. Looking through the general info, it looks like 85% on ITT basis is next to impossible to achieve just because of under-enrollment and misc dropouts (non-compliance?). Also, he could be counting slow responders who get there by 12 weeks but in the latest trial will likely not count.

Jon